FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
About half of Americans approve of using weight-loss drugs to treat obesity, new poll finds
New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are struggling with obesity ...
Jab rolled out to millions could cause neurological disorder
US health chiefs issued a warning about RSV jabs, which were only launched in Britain last year.In the UK, the condition is ...
shorenewsnetwork54m
Two arrested in Cape May County drug investigation
A man and woman from North Cape May were arrested Wednesday following a narcotics investigation that led to the seizure of drugs, ...
FDA Recalls Lay’s Potato Chips—Here’s What You Need to Know
The list of recalled food products being elevated to Class I (the highest recall level) by the U.S. Food and Drug Administration (FDA) is continuing to grow. This time, the organization has updated ...
STAT1h
Pharmalittle: We’re reading about FDA OK for Vertex non-opioid pain drug, vaccine advisory committee, and more
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
2025 Medical Device Cybersecurity Trends: What Will Shape The Industry?
What will the industry face or achieve in 2025? These trends will be critical in medical device cybersecurity.
FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Benefits Pro1h
Robert F. Kennedy Jr. worries anti-obesity drugs could ‘double insurance costs for employers’
President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...